About Freddie Dear
Freddie Dear is a director at Nocion Therapeutics.
Freddie Dear first appears on SEC filings in 2024.
Experience
This experience comes from Freddie Dear's profile and from SEC filings. For roles taken from filings, the years are when the filings name Freddie Dear in the role, so the role may have started earlier or lasted longer.
Nocion Therapeutics, Inc. Current
Investor Director (2024 – Present)
Director
2024 – Present · Watertown, MA
Develops inhaled medicines for people with chronic cough.
AT
Ascend Advanced Therapies Current
Strategic Advisor
2022 – Present
MC
Monograph Capital Current
Principal
2021 – Present
AT
Ascend Gene & Cell Therapies
Head of Corporate Development & Portfolio Manager
2021 – 2022
CT
Clade Therapeutics
Board Observer
2021
FT
Forcefield Therapeutics
Board Observer
2020 – 2021
QT
Quell Therapeutics
Board Observer
2019 – 2021
SL
Syncona Limited
Investment Partner
2017 – 2021
WT
Wellcome Trust
Finance and Investment graduate
2016 – 2018
TL
Tetragon Financial Group Limited
Internship
2015
Key Colleagues at Startups
The people Freddie Dear works with at each company, as listed on that company's latest Form D.
Nocion Therapeutics, Inc. · Form D, Mar 13, 2026
VM
Vijay Murthy
Director
JG
Julie Grant
Director
PO
Pini Orbach
Director
RH
Rosy Hu
Director
Matthew Frankel
Chief Medical Officer
Peter Courossi
Acting Chief Financial Officer
Richard Batycky
President and Chief Executive Officer, director
JE
James Ellis
Chief Scientific Officer
MH
Michael Higgins
Director